Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)

SHA:600196 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	67,049	59,749	61,592	86,922	113,862	125,791
Market Cap Growth	1.82%	-2.99%	-29.14%	-23.66%	-9.48%	93.27%
Enterprise Value	103,052	90,784	89,228	110,109	134,998	147,717
Last Close Price	26.97	24.56	24.46	33.95	46.54	51.04
PE Ratio	21.79	21.57	25.82	23.30	24.08	34.34
Forward PE	-	21.15	21.49	19.36	20.43	30.68
PS Ratio	1.70	1.46	1.49	1.98	2.92	4.15
PB Ratio	1.10	1.00	1.09	1.61	2.35	2.74
P/TBV Ratio	2.92	2.73	2.89	3.99	5.83	6.40
P/FCF Ratio	209.31	894.58	-	-	-	-
P/OCF Ratio	13.76	13.35	18.04	20.61	28.92	48.76
PEG Ratio	-	1.02	1.02	1.02	1.02	-
EV/Sales Ratio	2.61	2.21	2.15	2.51	3.46	4.87
EV/EBITDA Ratio	19.45	16.47	22.98	19.87	32.27	36.18
EV/EBIT Ratio	41.95	30.53	75.34	32.19	53.22	56.42
EV/FCF Ratio	321.70	1359.25	-	-	-	-
Debt / Equity Ratio	0.60	0.60	0.62	0.56	0.53	0.52
Debt / EBITDA Ratio	6.93	6.07	8.44	5.25	5.86	5.63
Debt / FCF Ratio	114.65	539.31	-	-	-	-
Asset Turnover	0.34	0.36	0.38	0.44	0.44	0.38
Inventory Turnover	2.91	2.90	3.01	3.77	3.82	3.03
Quick Ratio	0.66	0.68	0.73	0.78	0.75	0.71
Current Ratio	0.92	0.92	1.00	1.06	1.04	1.01
Return on Equity (ROE)	6.75%	6.03%	5.23%	7.70%	10.55%	9.25%
Return on Assets (ROA)	1.32%	1.61%	0.67%	2.13%	1.79%	2.05%
Return on Capital (ROIC)	1.60%	1.98%	0.84%	2.70%	2.21%	2.50%
Return on Capital Employed (ROCE)	3.00%	3.70%	1.50%	4.60%	4.00%	4.50%
Earnings Yield	4.90%	4.64%	3.87%	4.29%	4.15%	2.91%
FCF Yield	0.48%	0.11%	-3.12%	-1.92%	-0.91%	-1.48%
Dividend Yield	1.19%	1.30%	1.10%	1.24%	1.20%	0.84%
Payout Ratio	63.02%	74.35%	102.89%	63.64%	40.48%	50.09%
Buyback Yield / Dilution	1.39%	-0.02%	-2.40%	-1.74%	-	-
Total Shareholder Return	2.57%	1.28%	-1.29%	-0.50%	1.20%	0.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.